Please ensure Javascript is enabled for purposes of website accessibility
Search
▲ S&P 500 +---% | ▲ Stock Advisor +---%
Accessibility Log In Help
Accessibility Menu
Arrow-Thin-Down
S&P 500
6,791.69
+0.8%
+$53.25
Arrow-Thin-Down
DJI
47,207.12
+1.0%
+$472.51
Arrow-Thin-Down
NASDAQ
23,204.87
+1.1%
+$263.07
Arrow-Thin-Down
Bitcoin
111,514.00
+0.5%
+523.00
Arrow-Thin-Down
AAPL
$262.83
+1.3%
+$3.25
Arrow-Thin-Down
AMZN
$224.25
+1.4%
+$3.16
Arrow-Thin-Down
GOOG
$260.59
+2.7%
+$6.86
Arrow-Thin-Down
META
$738.67
+0.6%
+$4.67
Arrow-Thin-Down
MSFT
$523.49
+0.6%
+$2.93
Arrow-Thin-Down
NVDA
$186.28
+2.3%
+$4.12
Arrow-Thin-Down
TSLA
$433.88
-3.4%
-$15.10
Daily Stock Gainers Daily Stock Losers Most Active Stocks
Cory Renauer

Cory Renauer

TMFang4apples
LinkedIn
X @coryrenauer

Cory Renauer is a contributing Motley Fool healthcare analyst covering pharmaceuticals, biotechnology, and medical devices. Previously, Cory was a laboratory technician for the American Red Cross. He holds a bachelor’s degree in biology from Oakland University.

Recent Articles by Cory Renauer

institutional.png
Investor-thinking-about-stock-charts-getty
insider.png
institutional.png
insider.png
coffee-shop-investor-getty
Institutional.png
Institutional.png
insider.png
Institutional.png
insider.png
Institutional.png
Institutional.png
institutional.png
insider.png
smart-investor-studying-stock-charts-getty
Institutional.png
institutional.png
insider.png
institutional.png

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services